Wellington Management Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.2M | Sell |
5,664,733
-5,744,865
| -50% | -$80.4M | 0.01% | 586 |
|
|
2025
Q1 | $155M | Buy |
11,409,598
+1,561,647
| +16% | +$21.2M | 0.03% | 413 |
|
|
2024
Q4 | $201M | Sell |
9,847,951
-879,499
| -8% | -$17.9M | 0.04% | 367 |
|
|
2024
Q3 | $312M | Buy |
10,727,450
+903,683
| +9% | +$26.3M | 0.05% | 296 |
|
|
2024
Q2 | $228M | Buy |
9,823,767
+1,553,818
| +19% | +$36.1M | 0.04% | 349 |
|
|
2024
Q1 | $170M | Buy |
8,269,949
+995,232
| +14% | +$20.4M | 0.03% | 422 |
|
|
2023
Q4 | $156M | Sell |
7,274,717
-14,243
| -0.2% | -$306K | 0.03% | 447 |
|
|
2023
Q3 | $150M | Buy |
7,288,960
+250,784
| +4% | +$5.17M | 0.03% | 436 |
|
|
2023
Q2 | $208M | Buy |
7,038,176
+1,837,716
| +35% | +$54.2M | 0.04% | 380 |
|
|
2023
Q1 | $120M | Buy |
5,200,460
+78,730
| +2% | +$1.81M | 0.02% | 501 |
|
|
2022
Q4 | $142M | Buy |
5,121,730
+5,100,036
| +23,509% | +$142M | 0.03% | 455 |
|
|
2022
Q3 | $666K | Buy |
+21,694
| New | +$666K | ﹤0.01% | 1725 |
|
|
2018
Q1 | – | Sell |
-14,558
| Closed | -$228K | – | 2206 |
|
|
2017
Q4 | $228K | Buy |
+14,558
| New | +$228K | ﹤0.01% | 2106 |
|